BeOne Medicines Ltd
253 hedge funds and large institutions have $20.4B invested in BeOne Medicines Ltd in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 79 reducing their positions, and 37 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 79
7% more capital invested
Capital invested by funds: $19.1B → $20.4B (+$1.32B)
0.01% more ownership
Funds ownership: 4.65% → 4.67% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
5% less funds holding
Funds holding: 266 → 253 (-13)
24% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 37
32% less call options, than puts
Call options by funds: $31.3M | Put options by funds: $46M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$190M |
| 2 |
PIF
Public Investment Fund
Al Aqiq District, Riyadh,
Saudi Arabia
|
+$162M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$126M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$108M |
| 5 |
Temasek Holdings
Singapore
|
+$54.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$156M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$68.6M |
| 3 |
AG
Artal Group
Luxembourg
|
-$65.4M |
| 4 |
CBT
Capital Bank & Trust
Irvine,
California
|
-$53.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$52.7M |
ONC Hedge Fund Activity: Q3 2021 in Review
253 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2021, worth a combined $20.4B — up 6.9% from $19.1B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of ONC and 28 opened new positions — a net loss of 9 holders — while 79 trimmed existing stakes and 97 added.
The largest buyer was Invesco, adding an estimated $190M. The largest seller was Fidelity Investments, cutting an estimated $156M.
- 253 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2021, down from 266 in Q2 2021.
- Funds reported $20.4B of BeOne Medicines Ltd stock for Q3 2021, up 6.9% quarter-over-quarter.
- 28 funds opened new BeOne Medicines Ltd positions in Q3 2021 and 37 closed out, a net change of -9 holders.
- The largest BeOne Medicines Ltd buyer in Q3 2021 was Invesco, an estimated $190M added.
- The largest BeOne Medicines Ltd seller in Q3 2021 was Fidelity Investments, an estimated $156M sold.
Based on aggregated 13F filings for Q3 2021.